128 related articles for article (PubMed ID: 10703512)
1. [Nucleolar organizers and mitotic conditions in endometrial hyperplasia and carcinomaĭ].
Ellinidi VN; Pozharisskii KM
Vopr Onkol; 1999; 45(6):636-40. PubMed ID: 10703512
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of nucleolar organizer region activity in epithelial cells of hyperplastic endometrial carcinoma tissue].
Ellinidi VN; Novik VI; Pozharisskiĭ KM
Vopr Onkol; 2000; 46(2):187-90. PubMed ID: 10853418
[TBL] [Abstract][Full Text] [Related]
3. Changes in the number of silver-stained nucleolar organizer regions in the normal, preneoplastic, and neoplastic endometrium.
Niwa K; Murase T; Morishita S; Tanaka T; Shimokawa K; Tamaya T
Cancer Detect Prev; 1995; 19(5):436-40. PubMed ID: 7585730
[TBL] [Abstract][Full Text] [Related]
4. [Nucleolar organizer region-associated proteins and estrogen receptor of endometrial adenocarcinoma].
Wan ZM
Zhonghua Fu Chan Ke Za Zhi; 1993 May; 28(5):287-8, 315. PubMed ID: 8243149
[TBL] [Abstract][Full Text] [Related]
5. Digital image analysis of silver-stained nucleolar organizer region--associated proteins in endometrial cytologic samples.
Mahovlić V; Audy-Jurković S; Ovanin-Rakić A; Bilusić M; Veldić M; Babić D; Bozikov J; Danilović Z
Anal Quant Cytol Histol; 1999 Feb; 21(1):47-53. PubMed ID: 10068775
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar organizer regions as markers of endometrial proliferation: a study of normal, hyperplastic, and neoplastic tissue.
Brustmann H; Riss P; Naudé S
Hum Pathol; 1995 Jun; 26(6):664-7. PubMed ID: 7774898
[TBL] [Abstract][Full Text] [Related]
7. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
8. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
9. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
10. [The functional characteristics of the chromosomal nucleolus organizer regions of patients with endometrial cancer].
Buchinskaia LG; Polishchuk LZ; Ganina KP
Tsitol Genet; 1995; 29(4):32-7. PubMed ID: 8604524
[TBL] [Abstract][Full Text] [Related]
11. [A cytofluorometric study of the stability of secondary DNA structure in the epithelial cells in endometrial hyperplasia and cancer].
Ganina KP; Boĭko IuV
Tsitol Genet; 1996; 30(6):23-7. PubMed ID: 9139434
[TBL] [Abstract][Full Text] [Related]
12. AgNORs in endometrial lesions.
Kaushik R; Sharma S; Mahajan V; Gulati A; Sharma BB
Indian J Pathol Microbiol; 1999 Oct; 42(4):451-4. PubMed ID: 11127377
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar organizer regions in differentiated preneoplastic and neoplastic endometrial lesions.
Terlikowski S; Lenczewski A; Sulkowski S; Kulikowski M
Gynecol Obstet Invest; 1999; 47(3):205-9. PubMed ID: 10087419
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
[TBL] [Abstract][Full Text] [Related]
17. [Characteristic of cystic glandular hyperplasia as a precursor of endometrial carcinoma].
Yokosuka K; Teshima H; Yamakawa Y; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1241-6. PubMed ID: 7844442
[TBL] [Abstract][Full Text] [Related]
18. [Histochemical characterization of endometrial proliferation using AgNOR (nucleolus organizer region)].
Brustmann H; Riss P; Naudé S
Gynakol Geburtshilfliche Rundsch; 1994; 34(4):220-2. PubMed ID: 7819777
[TBL] [Abstract][Full Text] [Related]
19. Function of insulin-like growth factor (IGF-I) and its binding protein (IGFBP-1) in pathological proliferation of endometrium.
Waksmański B; Dudkiewicz J; Dabrowski S
Wiad Lek; 2001; 54(11-12):656-61. PubMed ID: 11928553
[TBL] [Abstract][Full Text] [Related]
20. [Difficulties and mistakes in the diagnosis of atypical endometrial hyperplasia].
Kxmel'nitskaia NM; Neĭshtadt EL; Khalimdzhanov ZK
Arkh Patol; 2006; 68(6):39-42. PubMed ID: 17290894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
